Bio-Techne

New additions to the R&D Systems AI-Engineered Designer Protein portfolio deliver improved consistency and scalability for stem cell, organoid, and regenerative medicine workflows. Read announcement: bit.ly/4eQQsnH

What does it take to scale cell therapy successfully? In our article with @Nature, our experts explore how the industry is tackling one of its biggest challenges. Read more: go.nature.com/4vAcxwm

We've worked with Refeyn to deliver a first-of-its-kind integrated workflow for characterizing charge and size variants in bispecific antibodies and biosimilars. Read the announcement: bit.ly/3RPlQKf

Today we shared our Q3 FY26 financial results, highlighting strong momentum in our spatial biology and proteomic analytical instrumentation growth pillars, as well as continued strength in our large pharma end market. Read more: bit.ly/4tfE30n

We’re streamlining our brand structure to make it easier for customers to find the solutions they need to move their work forward. Read the announcement: bit.ly/4tn9pU0